Huinno Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 78

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 33

Huinno General Information

Description

Developer of a clinical decision support system with AI-based cloud analysis software designed to provide biosignal data of ill patients. The company's system uses sensors and algorithms to monitor health data like blood pressure, and heart rate and also provides convenient diagnosis and treatment of patients with cardiac diseases such as arrhythmia, atrial fibrillation, and hypertension, enabling healthcare professionals to diagnose and make informed medical decisions while treating a patient.

Contact Information

Website
www.huinno.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4th floor, Rain Avenue
  • 19 Apgujeong-ro 79-gil
  • Seoul, Gangnam-gu 06011
  • South Korea
+82 00-0000-0000
Primary Industry
Monitoring Equipment
Other Industries
Decision/Risk Analysis
Diagnostic Equipment
Vertical(s)
LOHAS & Wellness, Digital Health, Wearables & Quantified Self, HealthTech
Corporate Office
  • 4th floor, Rain Avenue
  • 19 Apgujeong-ro 79-gil
  • Seoul, Gangnam-gu 06011
  • South Korea
+82 00-0000-0000

Huinno Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Huinno Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Accelerator/Incubator 000.00 Completed Generating Revenue
12. Accelerator/Incubator 000.00 Completed Generating Revenue
11. Accelerator/Incubator 000.00 Completed Generating Revenue
10. Later Stage VC (Series C) 07-Dec-2021 000.00 000.00 Completed Generating Revenue
9. Accelerator/Incubator 30-May-2021 000.00 Completed Generating Revenue
8. Later Stage VC (Series B) 21-Dec-2020 000.00 000.00 Completed Generating Revenue
7. Later Stage VC 01-Feb-2020 00.000 000.00 Completed Generating Revenue
6. Later Stage VC (Series A) 20-Aug-2019 00.00 0000 Completed Generating Revenue
5. Early Stage VC (Series A) 19-Aug-2016 $4.12M $4.12M 000.00 Completed Generating Revenue
4. Accelerator/Incubator 13-Nov-2015 Completed Pre-Clinical Trials
To view Huinno’s complete valuation and funding history, request access »

Huinno Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 000
To view Huinno’s complete cap table history, request access »

Huinno Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a clinical decision support system with AI-based cloud analysis software designed to provide biosignal data
Monitoring Equipment
Seoul, South Korea
78 As of 2024
000.00
000000000000 000.00

00000

ptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
0000000000 000000000
White Plains, NY
00 As of 0000
0000
0000000000 0 0000

00000

giat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in cul
0000000000 000000000
Bellevue, WA
000 As of 0000
000.00
00000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Huinno Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Retia Medical Venture Capital-Backed White Plains, NY 00 0000 0000000000 0 0000
Bardy Diagnostics Formerly VC-backed Bellevue, WA 000 000.00 000000&0 000.00
Agatsa Venture Capital-Backed Noida, India 00 00.00 000000 0
AliveCor Venture Capital-Backed Mountain View, CA 000 00000 000000000 00000
Stasis Venture Capital-Backed Los Angeles, CA 00 00.000 000000000000 00.000
You’re viewing 5 of 30 competitors. Get the full list »

Huinno Patents

Huinno Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240215892-A1 Device for monitoring biosignal Pending 31-Aug-2022 000000000
US-20240215925-A1 Method, system, and non-transitory computer-readable recording medium for estimating arrhythmia using composite artificial neural network Pending 30-Aug-2022 00000000
US-20240016434-A1 Method, system and non-transitory computer-readable recording medium for detecting and classifying beat in electrocardiogram signal Pending 08-Jul-2022 000000000
US-20240152808-A1 Method, system, and non-transitory computer-readable recording medium for managing training data of biosignal analysis model Pending 20-Jul-2021 000000000
US-20240153646-A1 Method, system, and non-transitory computer-readable recording medium for managing output data of biosignal analysis model Pending 16-Jul-2021 G16H50/70
To view Huinno’s complete patent history, request access »

Huinno Executive Team (7)

Name Title Board Seat
Yeongjoon Gil Ph.D Founder, Chief Executive Officer & President
Sunghoon Jeong Ph.D Chief Technology Officer
Ji Hwan Kim Chief Product Officer
You’re viewing 3 of 7 executive team members. Get the full list »

Huinno Board Members (1)

Name Representing Role Since
Ryu Jung-hee Self Board Member 000 0000
To view Huinno’s complete board members history, request access »

Huinno Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Huinno Investors (33)

Investor Name Investor Type Holding Investor Since Participating Rounds
AON Investment Venture Capital Minority 000 0000 000000 0
DAOL Investment Venture Capital Minority 000 0000 000000 0
FuturePlay Accelerator/Incubator Minority 000 0000 000000 0
Groom Investment PE/Buyout Minority 000 0000 000000 0
Meritz Securities Investment Bank Minority 000 0000 000000 0
You’re viewing 5 of 33 investors. Get the full list »

Huinno Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Huinno Aim 17-Aug-2022 0000 00000 00.000 Decision/Risk Analysis
To view Huinno’s complete investments history, request access »

Huinno FAQs

  • When was Huinno founded?

    Huinno was founded in 2014.

  • Who is the founder of Huinno?

    Yeongjoon Gil Ph.D, Steven Baek, and Yeongjoon Gil are the founders of Huinno.

  • Who is the CEO of Huinno?

    Yeongjoon Gil Ph.D is the CEO of Huinno.

  • Where is Huinno headquartered?

    Huinno is headquartered in Seoul, South Korea.

  • What is the size of Huinno?

    Huinno has 78 total employees.

  • What industry is Huinno in?

    Huinno’s primary industry is Monitoring Equipment.

  • Is Huinno a private or public company?

    Huinno is a Private company.

  • What is Huinno’s current revenue?

    The current revenue for Huinno is 00000.

  • How much funding has Huinno raised over time?

    Huinno has raised $70.2M.

  • Who are Huinno’s investors?

    AON Investment, DAOL Investment, FuturePlay, Groom Investment, and Meritz Securities are 5 of 33 investors who have invested in Huinno.

  • Who are Huinno’s competitors?

    Retia Medical, Bardy Diagnostics, Agatsa, AliveCor, and Stasis are some of the 30 competitors of Huinno.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »